Dinutuximab Antibody
Dinutuximab is a chimeric monoclonal antibody designed to target GD2, a disialoganglioside highly expressed on neuroblastoma cells. It is used in research for high-risk neuroblastoma, with applications in studying antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
Unituxin, APN311, APN-311
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Purity
>95% (May vary between batches)
Form
Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based) .
Molecular Weight
144.86 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA
Isotype
Human IgG1, kappa
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
(S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-6-hydroxyhexanoate
